<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04245891</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 17.11.01</org_study_id>
    <nct_id>NCT04245891</nct_id>
  </id_info>
  <brief_title>Neonatal Evaluation of Norepinephrine Infusion in Spinal Anesthesia for Cesarean Section</brief_title>
  <acronym>NECS</acronym>
  <official_title>Neonatal Evaluation of Norepinephrine Infusion in Spinal Anesthesia for Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This retrospective study aims to evaluate the fate of children born by cesarean section under
      spinal anesthesia with or without norepinephrine as vasopressor support for anesthesia. The
      main objective is to compare the initial Apgar score. The records of patients who received
      norepinephrine are compared to those without norepinephrine. To limit the biases of this type
      of study, the investigators will apply a propensity score that will include as a variable:
      age, ASA score, comorbidity, urgency. The patients analysed correspond to the period
      2016-2017.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2016</start_date>
  <completion_date type="Actual">November 30, 2017</completion_date>
  <primary_completion_date type="Actual">November 30, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>lactate level</measure>
    <time_frame>Just after the birth of the newborn baby</time_frame>
    <description>The primary endpoint is the Umbilical Cord Lactate levels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>APGAR Score</measure>
    <time_frame>1, 5 and 10 minutes after birth</time_frame>
    <description>APGAR Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Umbilical Cord arterial PH</measure>
    <time_frame>Just after the birth</time_frame>
    <description>Umbilical Cord arterial PH</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Umbilical Cord venous PH</measure>
    <time_frame>Just after the birth</time_frame>
    <description>Umbilical Cord venous PH</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maternal arterial tension during cesarean section</measure>
    <time_frame>0, 5,10,15, 20 25, 30,35,40 minutes after spinal anesthesia</time_frame>
    <description>maternal arterial tension during cesarean section</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidences of mother nausea and vomiting</measure>
    <time_frame>from beginning to cesarean section end</time_frame>
    <description>incidences of mother nausea and vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>use of vasopressors</measure>
    <time_frame>from beginning to cesarean section end</time_frame>
    <description>use of vasopressors</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">265</enrollment>
  <condition>Caesarean Section;Stillbirth</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>boli of ephedrine phenylephrine (45μg/mL-3mg/mL) if the variation of MAP &lt; 20% of baseline (MAP before spinal anaesthesia).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Protocol group</arm_group_label>
    <description>continuous infusion of norepinepineprhine at 20 μg/mL, started at 0.05 μg/kg/min. The dosage of norepinephrine was then adjusted to maintain a variation in MAP &lt; 20% of baseline. In case of failure, the use of a control group boli injection was possible.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        women over 18 years of age who need a caesarean section
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 18

          -  Spinal Anesthesia for Cesarean Section

        Exclusion Criteria:

          -  sub epidural cesarean section

          -  contraindication to spinal anesthesia (allergy, severe heart disease, coagulopathy)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant women</gender_description>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 27, 2020</study_first_submitted>
  <study_first_submitted_qc>January 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2020</study_first_posted>
  <last_update_submitted>January 28, 2020</last_update_submitted>
  <last_update_submitted_qc>January 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stillbirth</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

